Enodia Therapeutics raises €20.7M Seed round

The funding will be used to advance the company's lead program toward preclinical candidate selection and to accelerate the rollout of its small-molecule discovery platform, which uses machine learning and proteomics to degrade disease-causing proteins at the point of synthesis.

Source: https://www.globenewswire.com/news-release/2026/01/08/3001851/0/en/Argobio-launches-Enodia-with-20-7-million-seed-financing-to-advance-a-small-molecule-platform-for-targeted-protein-degradation-enabled-by-proteomics-and-machine-learning.html